Empirical therapy with ceftazidime combined with levofloxacin or once-daily amikacin for febrile neutropenia in patients with neoplasia: a prospective comparative study.
about
There should be no ESKAPE for febrile neutropenic cancer patients: the dearth of effective antibacterial drugs threatens anticancer efficacyCompliance with once-daily versus twice or thrice-daily administration of antibiotic regimens: a meta-analysis of randomized controlled trials.Comparison of ß-lactam plus aminoglycoside versus ß-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli.A prospective study of characteristics and outcomes of bacteremia in patients with solid organ or hematologic malignancies.
P2860
Empirical therapy with ceftazidime combined with levofloxacin or once-daily amikacin for febrile neutropenia in patients with neoplasia: a prospective comparative study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Empirical therapy with ceftazi ...... prospective comparative study.
@en
type
label
Empirical therapy with ceftazi ...... prospective comparative study.
@en
prefLabel
Empirical therapy with ceftazi ...... prospective comparative study.
@en
P2093
P2860
P1476
Empirical therapy with ceftazi ...... prospective comparative study.
@en
P2093
C Kalpadaki
D E Karageorgopoulos
E Koutsounaki
I Bompolaki
M E Falagas
P Mitsikostas
V Bozionelou
V Taktikou
P2860
P2888
P304
P356
10.1007/S10096-011-1454-0
P577
2011-10-31T00:00:00Z
P6179
1036648431